Login / Signup

Association of COVID-19 with respiratory syncytial virus (RSV) infections in children aged 0-5 years in the USA in 2022: a multicentre retrospective cohort study.

Lindsey WangPamela B DavisNathan BergerDavid C KaelberNora VolkowRong Xu
Published in: Family medicine and community health (2023)
COVID-19 was associated with a significantly increased risk for RSV infections among children aged 0-5 years in 2022. Similar findings were replicated for a study population of children aged 0-5 years in 2021. Our findings suggest that COVID-19 contributed to the 2022 surge of RSV cases in young children through the large buildup of COVID-19-infected children and the potential long-term adverse effects of COVID-19 on the immune and respiratory system.
Keyphrases
  • coronavirus disease
  • sars cov
  • respiratory syncytial virus
  • young adults
  • respiratory tract
  • clinical trial
  • randomized controlled trial
  • risk assessment
  • double blind
  • human health
  • drug induced